NCT07188441 2025-09-23
Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.
Sun Yat-sen University
Phase 2 Recruiting
Clinical Trials
8 trialsNCT07121322 2025-08-13
DACT-GCT
National Cancer Institute, Slovakia
Phase 2 Recruiting
NCT01873326 2025-07-03
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06309732 2024-03-13
GAMEC-II
Queen Mary University of London
Phase 2 Completed
NCT02414685 2020-08-07
TIP
National Cancer Institute, Slovakia
Phase 2 Completed
NCT02161692 2014-06-12
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Completed
NCT00198172 2014-06-03
Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors
Indiana University
Phase 2 Terminated
NCT00127049 2006-09-08
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Unknown